209
ADMA Biologics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
270
FY23:
257
FY24:
331
FY25:
467
(positive)
Change from FY21 to FY25
millions USD
FY21:
67.5
FY22:
78.1
FY23:
72.2
FY24:
157
FY25:
158
Total assets
Change from FY21 to FY25
millions USD
FY21:
276
FY22:
348
FY23:
329
FY24:
489
FY25:
624
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
30.4
FY22:
39.3
FY23:
49.8
FY24:
55.5
FY25:
69.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
105
FY22:
157
FY23:
144
FY24:
84.1
FY25:
77.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
141
FY22:
152
FY23:
135
FY24:
349
FY25:
477
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
276
FY22:
348
FY23:
329
FY24:
489
FY25:
624
All amounts in millions USD